Year: 2004
Type: review
Study design: Observational Study
Abstract: Rotavirus remains the most common cause of severe, dehydrating diarrhea among children worldwide.Several rotavirus vaccines are under development.Decisions about new vaccine introduction will require reliable data on disease impact.The Asian Rotavirus Surveillance Network, begun in 2000 to facilitate collection of these data, is a regional collaboration of 36 hospitals in nine countries or areas that conduct surveillance for rotavirus hospitalizations using a uniform World Health Organization protocol.We summarize the Network's organization and experience from August 2001 through July 2002.During this period, 45% of acute diarrheal hospitalizations among children 0-5 years were attributable to rotavirus, higher than previous estimates.Rotavirus was detected in all sites year-round.This network is a novel, regional approach to surveillance for vaccine-preventable diseases.Such a network should provide increased visibility and advocacy, enable more efficient data collection, facilitate training, and serve as the paradigm for rotavirus surveillance activities in other regions.I n recent years, several international agencies, including the World Health Organization (WHO), the Global Alliance for Vaccines and Immunization (GAVI), and the Children's Vaccine Program at the Program for Appropriate Technology in Health (PATH), have identified the accelerated development and introduction of a rotavirus vaccine to be among their highest priorities.This decision was made based on the high incidence of rotavirus, the most common cause of severe diarrhea in children worldwide.An estimated 440,000 children die of rotavirus each year (1), and in developing countries, 5% of all deaths in children <5 years of age are due to rotavirus.Furthermore, rotavirus is responsible for 25% to 50% of all hospitalizations of children for diarrhea in both industrialized and developing countries (2).After 2 decades of vaccine development and testing, the principles for making safe and effective, live oral vaccines have been firmly established, and several new candidate vaccines are currently in the late stage of development (3).Given the importance of rotavirus, GAVI has initiated the Accelerated Development and Introduction Program to expedite the development, evaluation, and introduction of rotavirus vaccines into the poorest countries with the goal of preventing most rotavirus deaths and hospitalizations within the next decade.
Source: Emerging infectious diseases
Authors: Joseph Bresee, Zhao-Yin Fang, Bei Wang, E.A.S. Nelson, John Tam, Yati Soenarto, Siswanto Agus Wilopo, Paul Kilgore, Jung Soo Kim, Jung Oak Kang, Wong Swee Lan, Chan Lee Gaik, Kyaw Moe, Kow-Tong Chen, Chuleeporn Jiraphongsa, Yaowapa Pongsuwanna, Nguyen Van Man, Phan Van Tu, Le Thi Luan, Erik Hummelman, Jon R. Gentsch, Roger Glass, the members of the Asian Rotavirus Surveillance Network
Institutions: Centers for Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Southeast University, Chinese University of Hong Kong, Universitas Gadjah Mada, International Vaccine Institute, Jeonbuk National University, Hanyang University, Sarawak General Hospital, Ministry of Health, Department of Health, Ministry of Health and Welfare, Ministry of Public Health, Institut Pasteur in Ho Chi Minh City
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2133113060
